New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer Therapies. Read more about New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer Therapies.
Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma. Read more about Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma.
Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers. Read more about Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers.
Updates in the Use of Targeted Therapies for Gynecologic Cancers. Read more about Updates in the Use of Targeted Therapies for Gynecologic Cancers.
Launching an International Community of Practice in Hematology/Oncology Medical Education. Read more about Launching an International Community of Practice in Hematology/Oncology Medical Education.
A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma. Read more about A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma.
From Boring to Bravo! Using Learning Science to Create Memorable Presentations. Read more about From Boring to Bravo! Using Learning Science to Create Memorable Presentations.
Structural Sexism and Cancer Care: The Effects on the Patient and Oncologist. Read more about Structural Sexism and Cancer Care: The Effects on the Patient and Oncologist.
Microaggressions, Bias, and Equity in the Workplace: Why Does It Matter, and What Can Oncologists Do? Read more about Microaggressions, Bias, and Equity in the Workplace: Why Does It Matter, and What Can Oncologists Do?
